MICROPORT CARDIO.MEDTECH. Market Cap ($107.57 Million)
Market Cap & Net Worth: MICROPORT CARDIO.MEDTECH. (72X)
MICROPORT CARDIO.MEDTECH. market cap. MICROPORT CARDIO.MEDTECH. (F:72X) has a market capitalization of $107.57 Million (€92.01 Million) as of November 4, 2026. Listed on the F stock exchange, this Germany-based company holds position #18732 globally and #1732 in its home market, demonstrating a -41.66% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MICROPORT CARDIO.MEDTECH.'s stock price €0.25 by its total outstanding shares 1273028439 (1.27 Billion). Also see cash efficiency ratio of MICROPORT CARDIO.MEDTECH. for how efficiently the company converts equity into cash flow.
MICROPORT CARDIO.MEDTECH. Market Cap History (2021–2026)
MICROPORT CARDIO.MEDTECH. market cap history from 2021 to 2026. Data shows change from $610.20 Million to $366.87 Million (-33.09% CAGR). Check 72X share price today for real-time trading data and today's change.
MICROPORT CARDIO.MEDTECH. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MICROPORT CARDIO.MEDTECH.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 72X net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.19x
MICROPORT CARDIO.MEDTECH.'s market cap is 0.19 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $610.20 Million | $200.81 Million | -$183.26 Million | 3.04x | N/A |
| 2022 | $452.44 Million | $251.03 Million | -$454.39 Million | 1.80x | N/A |
| 2023 | $218.78 Million | $336.21 Million | -$471.53 Million | 0.65x | N/A |
| 2024 | $66.97 Million | $361.56 Million | -$49.45 Million | 0.19x | N/A |
Competitor Companies of 72X by Market Capitalization
Companies near MICROPORT CARDIO.MEDTECH. in the global market cap rankings as of November 4, 2026. Also see 72X current and non-current assets for a full breakdown of the balance sheet.
Key companies related to MICROPORT CARDIO.MEDTECH. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $191.55 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $117.68 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #227 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $191.55 Billion | $110.16 |
| #204 | Stryker Corporation | NYSE:SYK | $117.68 Billion | $306.81 |
| #227 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $99.29 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of MICROPORT CARDIO.MEDTECH. (2021–2026)
Market capitalization of MICROPORT CARDIO.MEDTECH. from 2021 to today. Between 2021 and today, MICROPORT CARDIO.MEDTECH.'s market cap moved from $610.20 Million to $ 366.87 Million, with a yearly change of -33.09%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €366.87 Million | +126.15% |
| 2025 | €162.23 Million | +142.22% |
| 2024 | €66.97 Million | -69.39% |
| 2023 | €218.78 Million | -51.64% |
| 2022 | €452.44 Million | -25.85% |
| 2021 | €610.20 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of MICROPORT CARDIO.MEDTECH. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $107.57 Million USD |
| MoneyControl | $107.57 Million USD |
| MarketWatch | $107.57 Million USD |
| marketcap.company | $107.57 Million USD |
| Reuters | $107.57 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About MICROPORT CARDIO.MEDTECH.
MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People's Republic of China and internationally. The company engages in research and development, manufacture, and sale of medical devices in the field of left atrial appendage, and treating valv… Read more